Nougues Maximo F's Form 4/A amendment
AmendedPuma Biotechnology, Inc. (PBYI) · filed Aug 4, 2022
- Accession no.
- 0001437749-22-018991
- Filed
- Aug 4, 2022
- Trade date
- Jul 5, 2022
- Filing delay
- 30 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jul 7, 2022
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $24.5K. It was filed 30 days after the trade.
This amendment replaces 0001437749-22-016850 (filed Jul 7, 2022).
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nougues Maximo FCIK 0001758507 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | Common Stock | SSaleDisposed | −9,328 | $2.63 | −$24,532.64 | 111,738 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.